[ Price : $8.95]
FDA accepts for review an Accord BioPharma BLA for HLX02, a proposed trastuzumab (Roches Herceptin) biosimilar for treating certai...[ Price : $8.95]
FDA issues a draft guidance recommending to applicants and manufacturers drug shortage information to be communicated to FDA to as...[ Price : $8.95]
The political newsletter Roll Call says efforts to reauthorize a pandemic preparedness bill are likely to include a debate over gr...[ Price : $8.95]
FDA releases the form FDA-483 with three observations issued following an inspection at the Sugar Land, TX-based QuVa Pharma outso...[ Price : $8.95]
CDER director Patrizia Cavazzoni tells the Alliance for a Stronger FDA that the Center is in growth mode after the user fee reauth...[ Price : $8.95]
FDA approves a Synapse Biomedical PMA for the NeuRx Diaphragm Pacing System for use in patients with spinal cord injuries who rely...[ Price : $8.95]
FDA outlines research into potential pharmacodynamic biomarkers for biosimilar development.[ Price : $8.95]
Federal Register notice: FDA establishes a docket to obtain information and comments to help assess whether in-home disposal produ...